NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway.
NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway.
复制标题
DOI:
10.1002/cncr.24397
复制
发表时间:
2009-07-15
期刊:
影响因子:
6.2
通讯作者:
Mor, Gil
中科院分区:
文献类型:
--
作者:
Alvero, Ayesha B.;Montagna, Michele K.;Chen, Rui;Kim, Ki Hyung;Kyungjin, Kim;Visintin, Irene;Fu, Han-Hsuan;Brown, David;Mor, Gil
Resistance to apoptosis is one of the key events that confer chemo-resistance and is mediated by over-expression of anti-apoptotic proteins, which inhibit caspase activation. The objective of this study was to evaluate whether the activation of an alternative cell death pathway (caspase-independent) could promote death in chemo-resistant ovarian cancer cells. We report the characterization of NV-128 as an inducer of cell death through a caspase-independent pathway. Primary cultures of epithelial ovarian cancer cells (EOC) were treated with increasing concentration of NV-128 and GI50 was determined using Cell titer 96 assay. Apoptotic proteins were characterized by western blot analyses, Caspase Glo assays, immunohistochemistry, and flow cytometry. Protein-protein interactions were determined using immunoprecipitation. In vivo activity was measured in a xenograft mice model. NV-128 is able to induce significant cell death in both Paclitaxel- and Carboplatin- resistant EOC cells with GI50 between 1 and 5 ug/ml. Cell death was characterized by chromatin condensation but was caspase-independent. The activated pathway involved the down-regulation of phospho-AKT, phospho- mTOR, and phospho-S6 kinase, and the mitochondrial translocation of Beclin-1 followed by nuclear translocation of EndoG. We have characterized a novel compound, which inhibits mTOR and promotes caspase-independent cell death. Our results indicate that inhibition of mTOR may represent a relevant pathway for induction of cell death in cells resistant to the classical caspase-dependent apoptosis. These findings demonstrate the possibility of using therapeutic drugs, such as NV-128, which could have beneficial effects in chemo-resistant ovarian cancer patients.
登录
查看更多内容
影响因子:
11.2
作者:
Kelly, MG;Alvero, AB;Mor, G
通讯作者:
Mor, G
影响因子:
5.3
作者:
Fingar, DC;Richardson, CJ;Blenis, J
通讯作者:
Blenis, J
影响因子:
7.4
作者:
Kluger, Harriet M.;McCarthy, Mary M.;Alvero, Ayesha B.;Sznol, Mario;Ariyan, Stephan;Camp, Robert L.;Rimm, David L.;Mor, Gil
通讯作者:
Mor, Gil
影响因子:
3.7
作者:
Furuya, D;Tsuji, N;Watanabe, N
通讯作者:
Watanabe, N
影响因子:
6.2
作者:
Alvero, AB;O'Malley, D;Mor, G
通讯作者:
Mor, G